CardioFocus has reported one-year follow-up data from a trial of its HeartLight endoscopic ablation system as a treatment for atrial fibrillation.
HeartLight consists of an illuminating endoscope that provide physicians with direct visualisation within a beating heart, in real-time and without radiation.
The system also features a dynamically adjustable balloon catheter for improved contact with the pulmonary vein ostium and uses laser energy for precise ablation.
The study demonstrated a 99% acute pulmonary vein isolation rate and a 60% chronic clinical success rate from a single catheter ablation procedure.
After a median follow up of 402 days, 24 patients (60%) remained free of any symptomatic or documented atrial fibrillation episode without anti-arrhythmic drugs after a single procedure.
Lead investigator Andreas Metzner said that the initial catheter ablation procedures using the HeartLight endoscopic ablation system allowed the researchers to achieve a high pulmonary vein isolation rate acutely, using only a single compliant balloon-equipped catheter to perform the ablation.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
”We expect future outcomes to show that the rate of single procedure clinical success continues to improve with procedural experience,” Metzner said.